{"transactions":[{"id":713970,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-08T02:03:00.000Z","date":"2026-07-06","kind":"grant","planned":false,"acquired":true,"shares":41501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":87841,"derivative":{"exercise_price":1.2,"expiration_date":"2036-07-06","underlying":"Common stock","underlying_shares":41501},"source":{"system":"sec-edgar","filing":"0001437749-26-022968","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926022968/rdgdoc.xml","form_type":"4"}},{"id":713969,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-08T02:03:00.000Z","date":"2026-07-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":23125,"price":1.24,"value":28675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person."}],"balance_after":114245,"source":{"system":"sec-edgar","filing":"0001437749-26-022968","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926022968/rdgdoc.xml","form_type":"4"}},{"id":721970,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:37:33.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":60483,"price":1.2,"value":72579.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026."}],"balance_after":137370,"source":{"system":"sec-edgar","filing":"0001437749-26-022364","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926022364/rdgdoc.xml","form_type":"4"}},{"id":975136,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-11T02:54:29.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":46340,"derivative":{"exercise_price":1.37,"expiration_date":"2035-12-08","underlying":"Common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-037474","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925037474/rdgdoc.xml","form_type":"4"}},{"id":975135,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T02:54:29.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":true,"shares":29339,"price":1.37,"value":40194.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person."}],"balance_after":76887,"source":{"system":"sec-edgar","filing":"0001437749-25-037474","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925037474/rdgdoc.xml","form_type":"4"}},{"id":975134,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T02:54:29.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":58276,"price":1.37,"value":79838.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025."}],"balance_after":106226,"source":{"system":"sec-edgar","filing":"0001437749-25-037474","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925037474/rdgdoc.xml","form_type":"4"}},{"id":1096491,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-07-03T01:03:36.000Z","date":"2025-06-30","kind":"purchase","planned":false,"acquired":true,"shares":4819,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":26275,"derivative":{"exercise_price":1.95,"exercise_date":"2025-06-30","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":4819},"source":{"system":"sec-edgar","filing":"0001437749-25-022065","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925022065/rdgdoc.xml","form_type":"4"}},{"id":1096490,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-03T01:03:36.000Z","date":"2025-06-30","kind":"purchase","planned":false,"acquired":true,"shares":4819,"price":2.075,"value":9999.425,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":47950,"source":{"system":"sec-edgar","filing":"0001437749-25-022065","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925022065/rdgdoc.xml","form_type":"4"}},{"id":1165969,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-04-26T01:38:27.000Z","date":"2025-04-23","kind":"purchase","planned":false,"acquired":true,"shares":13123,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":21456,"derivative":{"exercise_price":1.905,"exercise_date":"2025-04-23","expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":13123},"source":{"system":"sec-edgar","filing":"0001437749-25-013200","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925013200/rdgdoc.xml","form_type":"4"}},{"id":1165968,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-26T01:38:27.000Z","date":"2025-04-23","kind":"purchase","planned":false,"acquired":true,"shares":13123,"price":1.905,"value":24999.315,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":43131,"source":{"system":"sec-edgar","filing":"0001437749-25-013200","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925013200/rdgdoc.xml","form_type":"4"}},{"id":1386205,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-17T01:56:21.000Z","date":"2024-10-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":11565,"price":2.65,"value":30647.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person."}],"balance_after":30008,"source":{"system":"sec-edgar","filing":"0001437749-24-031410","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774924031410/rdgdoc.xml","form_type":"4"}},{"id":1386204,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-17T01:56:21.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":24193,"price":2.65,"value":64111.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024."}],"balance_after":41573,"source":{"system":"sec-edgar","filing":"0001437749-24-031410","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774924031410/rdgdoc.xml","form_type":"4"}},{"id":1414583,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-09-05T16:42:02.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":8333,"derivative":{"exercise_price":3,"exercise_date":"2024-09-03","expiration_date":"2029-09-03","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001437749-24-028511","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774924028511/rdgdoc.xml","form_type":"4"}},{"id":1414582,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:42:02.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":8333,"price":3,"value":24999.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased."}],"balance_after":17380,"source":{"system":"sec-edgar","filing":"0001437749-24-028511","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774924028511/rdgdoc.xml","form_type":"4"}},{"id":1844578,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-27T00:31:37.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":4280,"price":2.336,"value":9998.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased from the issuer in a registered direct offering that closed on June 23, 2023."}],"balance_after":135724,"source":{"system":"sec-edgar","filing":"0001437749-23-018552","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923018552/rdgdoc.xml","form_type":"4"}},{"id":1870859,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-02T22:24:02.000Z","date":"2023-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":20676,"price":1.77,"value":36596.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on May 18, 2023 and does not represent a sale by the Reporting Person."}],"balance_after":131444,"source":{"system":"sec-edgar","filing":"0001437749-23-016522","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923016522/rdgdoc.xml","form_type":"4"}},{"id":1883322,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T01:31:52.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":68265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":68265,"derivative":{"exercise_price":1.7,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":68265},"source":{"system":"sec-edgar","filing":"0001437749-23-015516","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923015516/rdgdoc.xml","form_type":"4"}},{"id":1883321,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-23T01:31:52.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":61389,"price":1.7,"value":104361.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  100% of the RSUs vested on May 18, 2023."}],"balance_after":152120,"source":{"system":"sec-edgar","filing":"0001437749-23-015516","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923015516/rdgdoc.xml","form_type":"4"}},{"id":1923237,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-07T20:45:05.000Z","date":"2022-05-12","kind":"grant","planned":false,"acquired":false,"shares":17347,"price":1.32,"value":22898.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4 incorrectly reported that 20,632 shares had been withheld due to a clerical error.  The corrected number is reported herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The original Form 4 incorrectly reported that 76,518 shares were beneficially owned following the reported transaction.  The corrected amount is reported herein."}],"balance_after":79803,"source":{"system":"sec-edgar","filing":"0001437749-23-009766","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923009766/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-05-18"}},{"id":2082515,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-19T13:00:29.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":8928,"price":1.68,"value":14999.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased from the Issuer in a private placement that closed on December 16, 2022."}],"balance_after":87446,"source":{"system":"sec-edgar","filing":"0001437749-22-029314","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922029314/rdgdoc.xml","form_type":"4"}},{"id":2139629,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-11T11:01:43.000Z","date":"2022-10-10","kind":"purchase","acquired":true,"shares":2000,"price":2.07,"value":4140.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in multiple trades ranging from $2.06 to $2.08 per share.  The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price."}],"balance_after":78518,"source":{"system":"sec-edgar","filing":"0001437749-22-023876","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922023876/rdgdoc.xml","form_type":"4"}},{"id":2266489,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-19T00:03:14.000Z","date":"2022-05-12","kind":"tax_withholding","acquired":false,"shares":20632,"price":1.32,"value":27234.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 14, 2022 and does not represent a sale by the Reporting Person."}],"balance_after":76518,"source":{"system":"sec-edgar","filing":"0001437749-22-012952","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922012952/rdgdoc.xml","form_type":"4"}},{"id":2295937,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-19T01:17:31.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":60000,"derivative":{"exercise_price":1.49,"expiration_date":"2032-04-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-22-009165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922009165/rdgdoc.xml","form_type":"4"}},{"id":2295936,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-19T01:17:31.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":50345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  100% of the RSUs vested on April 14, 2022."}],"balance_after":97150,"source":{"system":"sec-edgar","filing":"0001437749-22-009165","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922009165/rdgdoc.xml","form_type":"4"}},{"id":2672771,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-11T22:16:29.000Z","date":"2021-06-10","kind":"tax_withholding","acquired":false,"shares":7274,"price":4.35,"value":31641.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 21, 2021 and does not represent a sale by the Reporting Person."}],"balance_after":46805,"source":{"system":"sec-edgar","filing":"0001437749-21-014633","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921014633/rdgdoc.xml","form_type":"4"}},{"id":2738894,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-28T00:24:59.000Z","date":"2021-04-21","kind":"grant","acquired":true,"shares":75850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on May 21, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":75850,"derivative":{"exercise_price":3.49,"expiration_date":"2031-04-21","underlying":"Common Stock","underlying_shares":75850},"source":{"system":"sec-edgar","filing":"0001437749-21-009942","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921009942/rdgdoc.xml","form_type":"4"}},{"id":2738893,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-28T00:24:59.000Z","date":"2021-04-21","kind":"grant","acquired":false,"shares":21370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock.  100% of the RSUs vested on April 21, 2021."}],"balance_after":54079,"source":{"system":"sec-edgar","filing":"0001437749-21-009942","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921009942/rdgdoc.xml","form_type":"4"}},{"id":3095739,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-02T01:16:30.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":7895,"price":2.4,"value":18948.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person."}],"balance_after":32709,"source":{"system":"sec-edgar","filing":"0001437749-20-014425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920014425/rdgdoc.xml","form_type":"4"}},{"id":3167719,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-29T14:36:59.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":19312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The original Form 4 incorrectly reported the number of shares held following the reported transaction."}],"balance_after":40604,"source":{"system":"sec-edgar","filing":"0001437749-20-008785","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920008785/rdgdoc.xml","form_type":"4/A","original_submission_date":"2020-04-28"}},{"id":3168562,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-28T23:19:51.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":25540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on May 24, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":25540,"derivative":{"exercise_price":3.43,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":25540},"source":{"system":"sec-edgar","filing":"0001437749-20-008736","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920008736/rdgdoc.xml","form_type":"4"}},{"id":3168561,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-28T23:19:51.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":19312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020."}],"balance_after":21292,"source":{"system":"sec-edgar","filing":"0001437749-20-008736","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920008736/rdgdoc.xml","form_type":"4"}},{"id":3193545,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-28T01:56:06.000Z","date":"2020-03-11","kind":"tax_withholding","acquired":false,"shares":2582,"price":3.6,"value":9295.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4."}],"balance_after":21292,"source":{"system":"sec-edgar","filing":"0001437749-20-006390","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920006390/rdgdoc.xml","form_type":"4"}},{"id":3193544,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-28T01:56:06.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":6315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on January 29, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4."}],"balance_after":23874,"source":{"system":"sec-edgar","filing":"0001437749-20-006390","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920006390/rdgdoc.xml","form_type":"4"}},{"id":3443912,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-08-08T20:41:23.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":16871,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"balance_after":16871,"derivative":{"exercise_price":6.3,"exercise_date":"2019-08-06","expiration_date":"2024-08-06","underlying":"Common Stock","underlying_shares":16871},"source":{"system":"sec-edgar","filing":"0001437749-19-016067","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016067/rdgdoc.xml","form_type":"4"}},{"id":3443911,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Convertible promissory note","published_at":"2019-08-08T20:41:23.000Z","date":"2019-08-06","kind":"exercise","acquired":false,"price":0,"reported_value":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"derivative":{"exercise_price":3,"exercise_date":"2019-07-05","expiration_date":"2020-01-05","underlying":"Common Stock","underlying_shares":16871},"source":{"system":"sec-edgar","filing":"0001437749-19-016067","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016067/rdgdoc.xml","form_type":"4"}},{"id":3443910,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Convertible promissory note","published_at":"2019-08-08T20:41:23.000Z","date":"2019-07-05","kind":"purchase","acquired":true,"price":50000,"reported_value":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"derivative":{"exercise_price":8,"exercise_date":"2019-07-05","expiration_date":"2020-01-05","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001437749-19-016067","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016067/rdgdoc.xml","form_type":"4"}},{"id":3443909,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-08T20:41:23.000Z","date":"2019-08-06","kind":"exercise","acquired":true,"shares":16871,"price":3,"value":50613.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"balance_after":23071,"source":{"system":"sec-edgar","filing":"0001437749-19-016067","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016067/rdgdoc.xml","form_type":"4"}},{"id":3771838,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-07T21:40:56.000Z","date":"2018-11-05","kind":"purchase","acquired":true,"shares":1600,"price":2.564,"value":4102.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.54 to $2.58 per share.  The price reported above reflects the weighted average per share purchase price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001437749-18-019858","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918019858/rdgdoc.xml","form_type":"4"}},{"id":3790100,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-16T20:34:58.000Z","date":"2018-10-12","kind":"purchase","acquired":true,"shares":500,"price":2.636,"value":1318.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.58 to $2.65 per share.  The price reported above reflects the weighted average per share purchase price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":4600,"source":{"system":"sec-edgar","filing":"0001437749-18-018346","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918018346/rdgdoc.xml","form_type":"4"}},{"id":3808528,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-26T00:57:02.000Z","date":"2018-09-25","kind":"purchase","acquired":true,"shares":2850,"price":2.452,"value":6988.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.34 to $2.59 per share.  The price reported above reflects the weighted average per share purchase price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price."}],"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001437749-18-017460","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918017460/rdgdoc.xml","form_type":"4"}},{"id":3985593,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"director":true,"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-23T01:52:31.000Z","date":"2018-03-22","kind":"purchase","acquired":true,"shares":500,"price":1.9,"value":950.0,"ownership":{"direct":true},"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001437749-18-005274","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918005274/rdgdoc.xml","form_type":"4"}},{"id":3985590,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-22T18:25:14.000Z","date":"2018-03-21","kind":"purchase","acquired":true,"shares":750,"price":1.9,"value":1425.0,"ownership":{"direct":true},"balance_after":750,"source":{"system":"sec-edgar","filing":"0001437749-18-005236","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918005236/rdgdoc.xml","form_type":"4"}},{"id":3985588,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31817,"kind":"person","name":"McClung David","position":1,"cik":"0001686155","reported_name":"McClung David","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-22T18:24:56.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":159020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":159020,"derivative":{"exercise_price":2.6,"expiration_date":"2028-02-01","underlying":"Common stock","underlying_shares":159020},"source":{"system":"sec-edgar","filing":"0001437749-18-005234","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918005234/rdgdoc.xml","form_type":"4"}}]}